Prague Old Town Square

The D&O Diary is on assignment in Europe this week, with a first stop in Prague, the capital and historic heart of the Czech Republic. Nestled on the banks of the Vltava River, Prague is a living museum of architectural treasures. With its bridges, castles, and rich history, Prague is one of Europe’s most charming cities.

Continue Reading Prague
Sarah Abrams

As readers know, one aspect of President Trump’s exercise of his presidential powers has been his willingness to grant pardons to certain persons, including even, as it has turned out, corporations. In the following guest post, Sarah Abrams, Head of Claims Baleen Specialty, a division of Bowhead Specialty, takes a look at the possible D&O insurance implications for a policyholder that has been convicted of a crime but granted a pardon. I would like to thank Sarah for her willingness to allow me to publish her article as a guest post on this site. I welcome guest post submissions from responsible authors on topics of interest to this site’s readers. Please contact me directly if you would like to submit a guest post. Here is Sarah’s article. 

Continue Reading Guest Post: Pardon Me

Nessim Mezrahi

In the following guest post, Nessim Mezrahi identifies three factors that present the current state of play in the U.S. D&O market.  Nessim is co-founder and CEO of the data analytics firm SAR LLC.  SAR previously published a version of this article as a client alert on May 23, 2025.  I would like to thank Nessim for allowing me to publish this article as a guest post on this site. I welcome guest post submissions from responsible authors on topics of interest to the site’s readers. Please contact me directly if you would like to submit a guest post. Here is Nessim’s article.

Continue Reading Guest Post: The State of U.S. D&O Market: Three Factors Impacting the U.S. D&O Market
Sarah Abrams

Last fall the U.S. Supreme Court dismissed, as improvidently granted, the writ of certiorari in two pending securities lawsuits, including in the Meta Platforms/Facebook case (as discussed here). The Court’s dismissal of the writ of certiorari in the Facebook case had obvious implications for the immediate litigants in the case, as it left the prior circuit court ruling standing. But the dismissal also has important implications for litigants in other cases involving the same issues as were raised in the Facebook case.

In the following guest post, Sarah Abrams, Head of Claims Baleen Specialty, a division of Bowhead Specialty, considers the implication for those other litigants in those other cases in light of the Supreme Court’s dismissal of the writ of certiorari in the Facebook case. I would like to thank Sarah for allowing me to publish her article as a guest post on this site. I welcome guest post submissions from responsible authors in topics of interest to this site’s readers. Please contact me directly if you would like to submit a guest post. Here is Sarah’s article.

Continue Reading Guest Post: Location, Location, Location

Because the so-called “bump up” exclusion typically found in D&O insurance policies is a frequently litigated policy term, industry observers were closely watching Fourth Circuit’s consideration of the question whether the exclusion applies to the settlement of litigation relating to Towers Watson’s January 2016 merger with Willis Group Holdings. On May 28, 2025, the appellate court held that the exclusion precludes coverage for the $90 million settlement of the underlying litigation. As discussed below, the appellate court’s decision likely will not put an end to disputes about the applicability of the exclusion. A copy of the Fourth Circuit’s May 28 decision can be found here.

Continue Reading 4th Circ.: Bump-Up Exclusion Bars Towers Watson Settlement Coverage
Sarah Abrams

In the following guest post, Sarah Abrams, Head of Claims Baleen Specialty, a division of Bowhead Specialty, takes a look at important questions that are arising in litigation challenging Trump administration acts with regard to “DEI” — including one judge’s question about what exactly DEI is. The administration’s answer to the question could have important implications for companies, as discussed below. I would like to thank Sarah for allowing me to publish her article as a guest post on this site. I welcome guest post submissions from responsible authors on topics of interest to this site’s readers. Please contact me directly if you would like to submit a guest post. Here is Sarah’s article.

Continue Reading Guest Post: What is DEI?

Among the many executive orders launched at the outset of the current Trump administration was the January 23, 2025 Executive Order that declared the administration’s commitment to maintaining the U.S. at the “forefront of artificial intelligence (AI) innovation.” The Executive Order set out the administration’s commitment to removing policies and directives that “act as barriers to American AI innovation.”

The Executive Order meant a variety of things when it referred to removing barriers, and the statement does at least raise the question about what the administration’s – and in particular, the SEC’s – enforcement approach to AI will be, if the goal is to remove barriers. As discussed below, there are signs to suggest that the administration will continue to monitor and address AI-related misrepresentations, notwithstanding its commitment to removing barriers to AI innovation.  

Continue Reading What About AI-Related Enforcement Under the Trump Administration?

Two decisions last week by the New York Court of Appeals – New York’s highest court – may represent the end of plaintiffs’ lawyers’ recent attempts to turn the state’s courts into a focal point for derivative litigation involving non-U.S. companies. Both of the Court’s decisions affirmed the dismissals of derivative suits that had been filed in New York state court against directors of non-U.S. companies — Barclays and Bayer, respectively — asserting claims against them under their respective home countries’ laws. A copy of the court’s May 20, decision in the Barclays case can be found here. A copy of the court’s May 20 decision in the Bayer case can be found here.

Continue Reading NY’s Highest Court Affirms Dismissals of Derivative Suits Involving Non-US Companies

In order to try to stem the supposed tide of Delaware corporations reincorporating in other states (particularly Texas and Nevada), Delaware recently enacted a set of revisions to its corporate law. Whether or not the legislative changes are sufficient to reduce the number of so-called “DExits” remains to be seen. But the other states are not just standing by idly waiting to see what happens. They have been at work in their own corporate law laboratories. As discussed below, the legislatures of both Texas and Nevada have in recent days both passed significant revisions to their respective corporate laws. The changes not only represent significant shifts in the corporate law arena, but also could entail significant changes in the corporate litigation world, as well.

Continue Reading Delaware Amended Its Corporate Laws, So Texas and Nevada Did, Too